UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Redwood Financial Network Corp

Redwood Financial Network Corp lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 12.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 601 shares of the healthcare conglomerate’s stock after selling 88 shares during the quarter. Redwood Financial Network Corp’s holdings in UnitedHealth Group were worth $306,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Macroview Investment Management LLC raised its stake in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC lifted its stake in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares during the period. True Wealth Design LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $31,000. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the second quarter valued at $31,000. Finally, Signature Resources Capital Management LLC grew its position in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts recently commented on UNH shares. Barclays raised their target price on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Argus boosted their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Monday, August 19th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $614.17.

Read Our Latest Analysis on UnitedHealth Group

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Down 0.5 %

Shares of NYSE UNH opened at $594.10 on Tuesday. The stock has a market cap of $548.60 billion, a PE ratio of 36.31, a P/E/G ratio of 1.66 and a beta of 0.58. The company has a 50-day moving average of $560.97 and a 200 day moving average of $515.54. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.14 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.